Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06687187Completed

Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients

Role: lead

NCT06287554Completed

Effect of Early Implementation of Prone Positioning

Role: lead

NCT06216210Completed

Assessing the Impact of Opioid-Free Anesthesia Using the Modified Mulimix Technique.

Role: lead

NCT06216197Not ApplicableCompleted

Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block

Role: lead

NCT06148103Not ApplicableCompleted

A Comparison Between Dexmedetomidine and Propofol-fentanyl Infusions for Sedation for Colonoscopy Procedures

Role: lead

NCT05862220Completed

Correlation Between Computer Tomography Angiography and D-Dimer Level for the Diagnosis of Pulmonary Embolism

Role: lead

All 6 trials loaded